BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of October 23, 2026, BLRX trades at $2.10 with a market cap of $10.50M and a P/E ratio of 0.00. BLRX moved +1.53% today. Year to date, BLRX is -28.35%; over the trailing twelve months it is -44.23%. Its 52-week range spans $1.95 to $7.77. Analyst consensus is buy with an average price target of $26.00. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioLineRX Ltd (BLRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BLRX moved +1.53% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.10 |
| Market Cap | $10.50M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.77 |
| 52-Week Low | $1.95 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover BLRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.00.